Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Doxorubicin in Advanced Soft-tissue Sarcomas
NCT00755261Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in soft tissue sarcoma (STS), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Sep 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00755261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755261.